Avecho Biotechnology Ratios and Metrics

Market cap in millions AUD. Fiscal year is January - December.

Millions AUD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Apr '26 Apr 16, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Capitalization	35	33	8	11	28	28
Market Cap Growth	120.22%	317.27%	-28.57%	-59.76%	0.10%	-40.60%
Enterprise Value	30	27	3	8	24	23
Last Close Price	0.01	0.01	0.00	0.00	0.01	0.01
PS Ratio	28.19	26.71	7.00	23.42	24.41	34.71
PB Ratio	22.38	21.20	2.42	1.74	11.37	6.07
P/TBV Ratio	22.38	21.20	2.42	1.74	11.49	6.21
P/FCF Ratio	-	29.97	-	-	-	-
P/OCF Ratio	31.64	29.97	-	-	-	-
EV/Sales Ratio	24.44	21.96	2.85	17.81	21.69	28.84
EV/FCF Ratio	-	24.64	-	-	-	-
Debt / Equity Ratio	0.01	0.01	0.33	0.03	0.10	0.02
Debt / FCF Ratio	0.01	0.01	-	-	-	-
Net Debt / Equity Ratio	-2.98	-2.98	-0.40	-0.84	-0.50	-0.70
Net Debt / EBITDA Ratio	1.22	1.22	0.44	1.64	0.58	1.07
Net Debt / FCF Ratio	-4.21	-4.21	0.33	1.68	0.71	0.96
Asset Turnover	0.21	0.21	0.18	0.09	0.26	0.19
Inventory Turnover	4.80	4.80	3.93	2.07	1.12	1.93
Quick Ratio	9.68	9.68	2.70	7.83	2.97	6.31
Current Ratio	9.95	9.95	2.81	8.31	3.83	6.91
Return on Equity (ROE)	-182.91%	-182.91%	-64.72%	-78.08%	-67.30%	-95.01%
Return on Assets (ROA)	-40.85%	-40.85%	-31.11%	-40.10%	-33.99%	-49.50%
Return on Capital Employed (ROCE)	-61.80%	-61.80%	-93.30%	-52.80%	-89.80%	-74.90%
Earnings Yield	-12.66%	-13.36%	-39.40%	-30.98%	-8.50%	-12.40%
FCF Yield	-	3.34%	-50.09%	-28.67%	-6.23%	-11.99%
Buyback Yield / Dilution	-3.08%	-3.08%	-39.73%	-23.41%	-1.97%	-13.27%

Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.